Use of Maytenus Ilicifolia in the Treatment of Dyspepsia
只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已终止
赞助商
Casa Espirita Terra de Ismael
合作者
University of Sao Paulo
临床试验: NCT01408849
BioSeek: NCT01408849
关键词
抽象
This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).
日期
| 最后验证: | 06/30/2016 |
| 首次提交: | 07/28/2011 |
| 提交的预估入学人数: | 08/01/2011 |
| 首次发布: | 08/02/2011 |
| 上次提交的更新: | 07/24/2016 |
| 最近更新发布: | 07/25/2016 |
| 实际学习开始日期: | 01/31/2015 |
| 预计主要完成日期: | 12/31/2015 |
| 预计完成日期: | 12/31/2015 |
状况或疾病
Dyspepsia
干预/治疗
Drug: Maytenus
Drug: Omeprazole
相
相 2
手臂组
| 臂 | 干预/治疗 |
|---|---|
| Experimental: Maytenus Tea of Martens ilicifolia leaves | Drug: Maytenus 2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks |
| Active Comparator: Omeprazole Omeprazole as active comparator | Drug: Omeprazole Standard therapy |
资格标准
| 有资格学习的年龄 | 18 Years 至 18 Years |
| 有资格学习的性别 | All |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - age > 18 years - being literate - diagnosis of dyspepsia - initial SODA score > or = 25 Exclusion Criteria: - pregnancy - lactation - allergy to Maytenus species - fail to use the drug for 3 uninterrupted weeks - new onset serious adverse events, attributable to the drug - patient's request |
结果
主要结果指标
1. SODA score [8 weeks]
次要成果指标
1. Sydney classification [8 weeks]
